Calcimar

Active Ingredient(s): Calcitonin
FDA Approved: * April 17, 1978
Pharm Company: * SANOFI AVENTIS US
Category: Osteoporosis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Calcimar Overview

2JXZ,%%s1LS7IdentifiersAliasesCALCA, CALC1, CGRP, CGRP-I, CGRP1, CT, KC, PCT, calcitonin related polypeptide alpha, CalcitoninExternal IDsOMIM: 114130 HomoloGene: 88401 GeneCards: CALCA Gene location (Human)Chr.Chromosome 11 (human)[1]Band11p15.2Start14,966,668 bp[1]End14,972,354 bp[1]RNA expression patternMore reference expression dataGene ontologyMolecular function• hormone activity• calcitonin receptor binding• protein bindi...

Read more Calcimar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Calcitonin

Recent Calcimar Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Calcitonin
  • Injection: 100 iu/ml, 200 iu/ml, 200unit/ml, 400 iu/vial
  • Spray, Metered: 200 iu/spray, 200IU/actuation
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Calcitonin or a similar ingredient: (4 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA